Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain

A heteroaryl, aryl technology, applied in the field of heteroaryl aminosulfonyl phenyl derivatives used as sodium or calcium channel blockers in the treatment of pain, can solve sodium channel blockers and calcium channels Blocker side effects, etc.

Inactive Publication Date: 2010-02-10
VERTEX PHARMA INC
View PDF3 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0026] However, as mentioned above, the efficacy of sodium channel blockers and calcium channel blockers currently used in the above disease states is largely limited by a large number of side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
  • Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
  • Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0628] 4-(2,4-Dichloro-phenoxy)-butyric acid ethyl ester

[0629]

[0630] At 80°C, to 2,4-dichlorophenol (32.6g, 0.2mol), NaI (3g) and K 2 CO 3 (69 g, 0.5 mol) in DMF (500 mL) was added dropwise with ethyl 4-bromobutyrate (39 g, 0.2 mol). The reaction mixture was stirred at 80 °C for 2 hours until the reaction mixture became colorless. The cooled mixture was filtered and the filtrate was diluted with EtOAc (1000 mL), washed with water (3 x 500 mL), dried and concentrated to give crude butyrate (57 g) as a colorless oil.

[0631] 1 H-NMR (CDCl 3 ): δ7.34(d, 1H, J=8.8Hz), 7.16(dd, 1H, J 1 =8.8Hz,J 2 =2.4Hz), 6.84(d, 1H, J=8.8Hz), 4.15(q, 2H, J=7.2Hz), 4.06(t, 2H, J=7.2Hz), 2.54(t, 2H, J=7.2 Hz), 2.17(p.2H, 6.4), 1.25(t, 3H, J=7.2Hz).

[0632] 4-(2,4-Dichloro-phenoxy)-butanoic acid

[0633]

[0634] Add LiOH.H 2 O (12.6 g, 0.3 mol), the reaction mixture was stirred at room temperature (RT) for 5 hours. The mixture was washed with Et 2 O washed (3 x 200 mL), aci...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

Description

[0001] This application is a divisional application of the Chinese patent application whose application number is 2004800293492 (PCT / US2004 / 025827), the application date is August 9, 2004, and the title of the invention is the same as above. technical field [0002] The present invention relates to compounds useful as inhibitors of voltage-gated sodium and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using these compositions to treat various disorders. Background technique [0003] Na channels are central to the generation of action potentials in all excitable cells, such as neurons and muscle cells. They play key roles in excitable tissues, including the brain, gastrointestinal smooth muscle, skeletal muscle, peripheral nervous system, spinal cord, and airways. As such, they play key roles in various disease states such as epilepsy ( See, Moulard, B. and D. Bertrand (2002) "...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D285/135C07C311/46C07D277/52C07D239/52C07D239/42C07D417/12C07D413/12C07D401/12C07D209/92C07D409/12C07D405/12C07D261/16A61K31/635A61K31/403A61P43/00A61P25/04A61P29/00A61P19/02A61P25/06A61P25/00A61P9/06A61P1/00
Inventor J·E·冈萨雷斯三世A·P·特门E·马丁波罗N·齐默曼
Owner VERTEX PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap